How to Read a Certificate of Analysis
The short answer
A Certificate of Analysis, commonly called a COA, is a summary of test results associated with a particular material or batch. It can help a reader understand what was tested, which methods were reported, what results were obtained and whether those results met stated specifications.
A COA is not automatically proof of every quality attribute. Its value depends on traceability, sampling, test selection, method suitability, laboratory controls and whether the document can be connected reliably to the material being described.
Start with identity and traceability
Look for the product or material name, batch or lot number, test date, report or certificate number and the identity of the laboratory or issuing organization. The lot number on the document should correspond to the lot being discussed.
Dates matter. A test result describes the submitted sample at the time of testing. It does not, by itself, describe every future batch or prove how material was stored after the sample was collected.
Specification versus result
A specification is the acceptance criterion established for a test. A result is what the test reported for the sample. A clear COA should allow the reader to distinguish the two.
“Pass” is most useful when the underlying criterion and result are shown. Without them, the reader cannot see the threshold applied or how close the result was to it. Units, basis of calculation and qualifiers such as “not detected” or “below the quantitation limit” should also be clear.
Identity is not the same as purity
Identity testing asks whether the sample is consistent with the intended molecule. Techniques may include mass spectrometry, spectroscopy or a suitable combination of methods. A single chromatographic retention time may not be sufficiently specific by itself, because different compounds can sometimes behave similarly in one separation system.
Purity testing asks what proportion of the detected material corresponds to the main component under the conditions of a particular method. High-performance liquid chromatography (HPLC) is commonly used to separate components and report relative peak areas.
An HPLC area percentage is not automatically the same as the amount of peptide in a vial. It is method-dependent and may not account equally for water, counterions, residual solvents, inorganic material or substances that are not detected under the selected conditions.
Mass spectrometry and molecular identity
Mass spectrometry measures mass-to-charge information and can support molecular identity. The reported signal must be interpreted according to ionization, charge states, adducts and the expected molecular form. A matching mass is useful evidence, but it does not independently quantify every impurity or establish all aspects of composition.
This is why complementary methods can be stronger than relying on one test. One method may support identity while another addresses chromatographic purity, water content, residual solvent or quantity.
Quantity, assay and net content
Quantity-related terms require care. “Assay,” “peptide content,” “net content” and “purity” are not interchangeable. A result should state what is being measured, the method, the units and whether the value is reported on an as-is, dried or anhydrous basis.
For example, a chromatographic purity result can be high while the total mass includes components not represented by the primary chromatographic peak. A complete interpretation therefore depends on the analytical question and the set of tests performed.
Method suitability and validation
An analytical result is meaningful only if the procedure is suitable for its intended purpose. International guidance describes characteristics such as specificity or selectivity, accuracy, precision, range and robustness. Not every characteristic applies in the same way to every method, but the laboratory should be able to show that the procedure performs adequately for the measurement being reported.
The words “HPLC” or “mass spectrometry” alone do not describe the full method. Important details may include equipment, reference standards, sample preparation, columns, mobile phases, detection settings, system-suitability criteria and data-processing rules.
Questions a careful reader can ask
- Is the certificate tied to a specific lot?
- Who performed or issued the testing?
- Are test dates, methods, units, specifications and numerical results shown?
- Does identity testing use a suitably specific method or complementary methods?
- Is the meaning of “purity” or “assay” defined?
- Are important quality attributes outside the reported method acknowledged?
- Is there enough traceability to connect the tested sample to the described material?
- Does the document avoid implying conclusions broader than the tests performed?
What a COA does not establish by itself
A COA does not independently prove regulatory authorization, suitability for human use, clinical safety, clinical effectiveness, sterility, endotoxin control, long-term stability or correct storage unless those specific matters were appropriately tested and documented. It also does not guarantee that a submitted sample represents every unit or future lot.
Key points
- Begin with lot traceability, dates, laboratory identity and the tested material.
- Separate specifications from actual results.
- Identity, chromatographic purity and quantity are different analytical questions.
- HPLC area percentage should not automatically be read as vial content.
- Complementary, suitable methods provide a more complete picture than one result alone.
- Interpret only what the reported tests can support.
Primary references
- Health Canada. International Council for Harmonisation Guidelines — Q2(R2): Revision to Analytical Validation. https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/international-council-harmonisation/guidelines.html
- U.S. Food and Drug Administration. Q2(R2) Validation of Analytical Procedures. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/q2r2-validation-analytical-procedures
- U.S. Food and Drug Administration. Q6A Specifications: Test Procedures and Acceptance Criteria. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/q6a-specifications-test-procedures-and-acceptance-criteria-new-drug-substances-and-new-drug-products
- Health Canada. Good Manufacturing Practices Guide for Drug Products (GUI-0001). https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/gmp-guidelines-0001/document.html